Two sets of independently isolated measles virus temperature-sensitive mutants were quantitatively tested for complementation. Analysis of the nine possible combinations of representative mutants indicated that only one pair of mutants is noncomplementing. Thus, the measles virus mutants studied to date define five complementation groups.
Two sets of temperature-sensitive (ts) mutants of measles virus have been isolated and partially characterized (1, 6) . Bergholz et al.
(1) divided their mutants into three complementation groups (A, B, and C); similarly, Haspel et al. (6) classified their mutants into three complementation groups (I, II, and III). To further our understanding of the gene products involved in measles virus replication, a collaborative complementation study was undertaken. Our results indicate that five complementation groups are represented among the two sets of mutants.
Two different methods to test for complementation were used in this study. Method A basically followed the procedure of Haspel et al. (6) . The mutants to be tested were incubated at 25°C for 30 min in the presence of 3 ,ug of poly-Lornithine per ml (molecular weight, >165,000; Sigma Chemical Co.) either in various combinations or singly. mm2) Leighton tubes at a multiplicity of 0.2 to 2.0 PFU/cell. After a 2-h adsorption period at 33°C, the cell monolayers were rinsed with balanced salt solution, growth medium was added, and the cultures were incubated at 33°C for 5 h. Subsequent incubation was at 39°C. When doubly infected cells showed 75% measles virus cytopathic effect, they were frozen and thawed along with their corresponding singly infected cultures. Virus yields were determined by plaque assay in Vero cells at 33 and 39°C. The index of complementation was calculated as in method A.
One representative mutant was used from each complementation group previously identified independently by our laboratories. A total of nine possible combinations was analyzed (Table 1) . To simplify the nomenclature used to identify mutants in this study, numerical designations (101-124) were substituted for the alphabetical designations (A-X) used by Haspel et al. (6) . As previously, designations 1 through 9 were used for mutants isolated by Bergholz et al. (1) .
Complementation was observed between ts-120 and both ts-1 and ts-9. As indicated by complementation indexes of less than one, ts-120 and ts-4 definitely did not complement. Thus, group I mutants of Haspel et al. (6) and group B mutants of Bergholz et al.
(1) belong to the same complementation group. This is consistent with the similarities in the phenotypic properties of these mutants (1, 6). With one exception (i.e., ts-8 of Bergholz et al. [1] ), mutants in this complementation group (designated group B) are defective in virus-specific RNA and antigen synthesis at 39°C (Table 2) .
For reasons presently unknown, an unusually large proportion (28/33) of the ts mutants isolated to date belong to this complementation group.
ts-107 clearly complemented all three mutants against which it was tested. ts-107 is currently the only available mutant in this complementation group, which we have designated group C. Like group B mutants, ts-107 is defective in virus-specific RNA and antigen synthesis at 39°C; however, ts-107 shows no increased thermolability (Breschkin and Rapp, unpublished observations) and retains significant neurovirulence (2, 7). (Table 2) . Therefore, we have tentatively assigned ts-103 to complementation group E.
ts-1 and ts-9 (1) both complemented all three mutants against which they were tested, although the complementation indexes in two cases (ts-1 versus ts-103 and ts-9 versus ts-120) were rather low. For the present, we have assigned ts-1 to complementation group A and ts-9 to complementation group D. Group A is a third RNA-and antigen-negative complementation group (Table 2 ). The group D mutant is apparently defective in a function required for virus-induced hemadsorption.
ts mutants of two other paramyxoviruses, Sendai virus and Newcastle disease virus, have previously been isolated and characterized (3, 10, 12 
